Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126827531 | 12682753 | 1 | I | 20160509 | 20160811 | 20160825 | 20160825 | EXP | GB-MHRA-EYC 00143446 | GB-TEVA-685530ACC | TEVA | 63.00 | YR | F | Y | 100.00000 | KG | 20160825 | MD | GB | GB |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126827531 | 12682753 | 1 | PS | NAPROXEN SODIUM. | NAPROXEN SODIUM | 1 | Oral | 750 MILLIGRAM DAILY; | 1152718.75 | MG | Y | U | 74129 | 250 | MG | TID | |||
| 126827531 | 12682753 | 2 | SS | RAMIPRIL. | RAMIPRIL | 1 | Oral | 10 MILLIGRAM DAILY; | 24360 | MG | U | 77470 | 10 | MG | QD | ||||
| 126827531 | 12682753 | 3 | SS | MST CONTINUS | MORPHINE SULFATE | 1 | 40 MILLIGRAM DAILY; | 21158.3333 | MG | Y | U | 0 | 20 | MG | BID | ||||
| 126827531 | 12682753 | 4 | C | LANSOPRAZOLE. | LANSOPRAZOLE | 1 | 0 | ||||||||||||
| 126827531 | 12682753 | 5 | C | LAXIDO | POLYETHYLENE GLYCOL 3350POTASSIUM CHLORIDESODIUM BICARBONATESODIUM CHLORIDE | 1 | 0 | ||||||||||||
| 126827531 | 12682753 | 6 | C | LYRICA | PREGABALIN | 1 | 0 | ||||||||||||
| 126827531 | 12682753 | 7 | C | PARACETAMOL | ACETAMINOPHEN | 1 | 0 | ||||||||||||
| 126827531 | 12682753 | 8 | C | SERTRALINE | SERTRALINE HYDROCHLORIDE | 1 | 0 | ||||||||||||
| 126827531 | 12682753 | 9 | C | SIMVASTATIN. | SIMVASTATIN | 1 | 0 | ||||||||||||
| 126827531 | 12682753 | 10 | C | SIRDUPLA | 2 | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126827531 | 12682753 | 1 | Arthralgia |
| 126827531 | 12682753 | 2 | Essential hypertension |
| 126827531 | 12682753 | 3 | Arthralgia |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126827531 | 12682753 | HO |
| 126827531 | 12682753 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126827531 | 12682753 | Acute kidney injury | |
| 126827531 | 12682753 | Confusional state | |
| 126827531 | 12682753 | Coordination abnormal | |
| 126827531 | 12682753 | Diarrhoea | |
| 126827531 | 12682753 | Somnolence | |
| 126827531 | 12682753 | Toxicity to various agents | |
| 126827531 | 12682753 | Vomiting |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126827531 | 12682753 | 1 | 20120223 | 20160523 | 0 | |
| 126827531 | 12682753 | 2 | 20090907 | 0 | ||
| 126827531 | 12682753 | 3 | 20141127 | 20160523 | 0 |